No Data
No Data
H.C. Wainwright Upgrades Dogwood Therapeutics(DWTX.US) to Buy Rating, Raises Target Price to $10
Express News | HC Wainwright & Co. Upgrades Dogwood Therapeutics to Buy, Announces $10 Price Target
Nasdaq Tumbles Over 400 Points; Netflix Posts Upbeat Earnings
Express News | Dogwood Therapeutics Shares Halted On Downside; Shares Up 36 %
12 Health Care Stocks Moving In Wednesday's After-Market Session
Dogwood Therapeutics Regains Nasdaq Compliance